Baxter International Inc. (BAX)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
José E. Almeida
Employees:
60,000
ONE BAXTER PKWY, DF2-1W, DEERFIELD, IL 60015
8479482000

Baxter International Inc. develops and provides a portfolio of healthcare products worldwide. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries.

Data derived from most recent annual or quarterly report
Market Cap 18.129 Billion Shares Outstanding506.405 Million Avg 30-day Volume 4.136 Million
P/E Ratio7.4111 Dividend Yield3.0737 EPS-5.83
Price to Revenue1.2582 Debt to Equity2.0197 EBITDA1.868 Billion
Price to Book Value2.3713 Operating Margin4.1133999999999995 Enterprise Value29.98 Billion
Current Ratio1.938 EPS Growth2.081 Quick Ratio1.337
1 Yr BETA 0.652 52-week High/Low 52.25 / 30.76 Profit Margin17.0433
Operating Cash Flow Growth11.5358 Free Cash Flow to Firm (FCFF) TTM 2.975 Billion Free Cash Flow to Equity (FCFE) TTM1.358 Billion
Altman Z-Score2.0323
Earnings Report2024-02-15
View SEC Filings from BAX instead.

View recent insider trading info

Baxter International Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding BAX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BAX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-12-05 by GRADE JOEL T.
  • 4: filed on 2023-12-05 by STEVENS BRIAN
  • 3: filed on 2023-10-19 by GRADE JOEL T.
  • 4: filed on 2023-09-06 by SONIG ALOK
  • 4: filed on 2023-09-06 by BORZI JAMES W
  • 4: filed on 2023-08-23 by RUSCKOWSKI STEPHEN H
  • 3: filed on 2023-08-23 by RUSCKOWSKI STEPHEN H
  • 4: filed on 2023-07-03 by AMPOFO WILLIAM A. II
  • 3: filed on 2023-07-03 by AMPOFO WILLIAM A. II
  • 4: filed on 2023-06-05 by STEVENS BRIAN

    • Events (8k)

  • 8-K: filed on 2023-11-02:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-10-03:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-10-02:
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2023-08-21:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-07-27:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-07-06:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-29:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-09:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-04:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-27:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    STEVENS BRIAN SVP, CAO & CONTROLLER

    • Officer
    		 53,532 2023-12-01 7

    GRADE JOEL T. EVP AND CFO

    • Officer
    		 53,177 2023-12-01 2

    BORZI JAMES W EVP, CHIEF SUPPLY CHAIN OFFICE

    • Officer
    		 32,300 2023-09-01 3

    SONIG ALOK EVP, GROUP PRESIDENT, PHARM

    • Officer
    		 31,512 2023-09-01 3

    RUSCKOWSKI STEPHEN H

    • Director
    		 0 2023-08-21 2

    AMPOFO WILLIAM A. II

    • Director
    		 0 2023-06-29 2

    TOTH CHRISTOPHER A. EVP, GROUP PRES, KIDNEY CARE

    • Officer
    		 106,358 2023-06-01 2

    ROSENBLOOM DAVID S. SVP AND GENERAL COUNSEL

    • Officer
    		 55,645 2023-06-01 2

    OESTERLE STEPHEN N.

    • Director
    		 21,336 2023-05-02 1

    MORRISON PATRICIA

    • Director
    		 14,984 2023-05-02 1

    WILVER PETER M

    • Director
    		 7,111 2023-05-02 1

    SMITH CATHY R

    • Director
    		 16,130 2023-05-02 1

    SCHLICHTING NANCY M

    • Director
    		 8,099 2023-05-02 1

    WENDELL AMY MCBRIDE

    • Director
    		 17,894 2023-05-02 1

    MAHONEY MICHAEL F

    • Director
    		 30,089 2023-05-02 1

    SHAFER DAVID BRENT

    • Director
    		 7,101 2023-05-02 1

    WILKES DAVID S.

    • Director
    		 10,034 2023-05-02 1

    STROUCKEN ALBERT P L

    • Director
    		 37,531 2023-03-20 1

    RASUL REAZ EVP, GROUP PRES, HEALTHCARE

    • Officer
    		 26,765 2023-03-20 5

    KNIGHT HEATHER EVP, GROUP PRES, MEDICAL

    • Officer
    		 53,110 2023-03-20 5

    ALMEIDA JOSE E CHAIRMAN, CEO AND PRESIDENT

    • Officer
    		 408,453 2023-03-02 3

    MASON JEANNE K SVP, HUMAN RESOURCES

    • Officer
    		 138,821 2023-03-02 4

    SACCARO JAMES EVP, CHIEF FINANCIAL OFFICER

    • Officer
    		 177,899 2023-03-02 3

    FRANZI CRISTIANO SVP, PRESIDENT, EMEA

    • Officer
    		 102,145 2023-03-02 3

    KUNZLER JACQUELINE SVP, CHIEF QUALITY OFFICER

    • Officer
    		 22,625 2023-03-02 4

    FLYNN STEVEN SVP, PRESIDENT, APAC

    • Officer
    		 31,080 2023-03-01 2

    HELLMAN PETER S

    • Director
    		 30,895 2022-05-03 0

    CHEN THOMAS F

    • Director
    		 24,914 2022-05-03 0

    FORSYTH JOHN D

    • Director
    		 28,034 2022-04-01 0

    MARTIN SEAN SVP AND GENERAL COUNSEL

    • Officer
    		 83,640 2022-03-02 0

    ACCOGLI GIUSEPPE EVP, CHIEF OPERATING OFFICER

    • Officer
    		 131,621 2022-03-02 0

    FRYE ANDREW SVP, PRESIDENT, APAC

    • Officer
    		 56,456 2022-03-02 0

    STALLKAMP THOMAS T

    • Director
    		 34,176 2021-05-04 0

    GAVIN JAMES R III

    • Director
    		 0 2020-09-11 0

    BLANCO ALEX N SVP, CHIEF SUPPLY CHAIN OFFCR

    • Officer
    		 0 2020-03-23 0

    THIRD POINT LLC

    LOEB DANIEL S

    • Director
    • SEE REMARKS
    		No longer subject to file 2019-05-16 0

    PLEAU SCOTT SVP, OPERATIONS

    • Officer
    		 20,076 2019-03-29 0

    EYRE BRIK V SVP, PRESIDENT, AMERICAS

    • Officer
    		 0 2019-02-28 0

    SHAPAZIAN CAROLE J

    • Director
    		 15,968 2018-12-13 0

    STORM KORNELIS J.

    • Director
    		 22,512 2018-03-28 0

    KARP CAROLINE SVP, CONTROLLER

    • Officer
    		 12,557 2018-03-05 0

    VIBERT PAUL CVP, INTERNATIONAL

    • Officer
    		 51,283 2017-03-06 0

    SCHABACKER MARCUS CVP, CHIEF SCIENTIFIC OFFICER

    • Officer
    		 35,602 2017-03-06 0

    SCHARF DAVID P. CVP AND GENERAL COUNSEL

    • Officer
    		 109,789 2017-02-21 0

    FELICELLI ROBERT CVP, BUSINESS TRANSFORMATION

    • Officer
    		 0 2016-12-30 0

    CHOWDHRY UMA

    • Director
    		 9,874 2016-05-03 0

    SCHAAF JILL M CVP, RENAL

    • Officer
    		 48,608 2016-03-07 0

    LAWRENCE TIMOTHY P CVP, OPERATIONS

    • Officer
    		 34,478 2016-03-07 0

    BUFALINO SEBASTIAN J CVP, CONTROLLER

    • Officer
    		 21,561 2016-03-03 0

    ISLAM MUNIB

    • Director
    		 0 2015-09-29 0

    PARKINSON ROBERT L JR CHAIRMAN OF THE BOARD AND CEO

    • Officer
    • Director
    		 693,401 2015-08-11 0

    HANTSON LUDWIG CORPORATE VICE PRESIDENT

    • Officer
    		 109,990 2015-06-01 0

    FOSLER GAIL D

    • Director
    		 32,566 2015-05-05 0

    HOCKMEYER WAYNE T

    • Director
    		 12,359 2015-05-05 0

    DEVITT BLAKE E

    • Director
    		 19,892 2015-05-05 0

    HOMBACH ROBERT J. CORPORATE VICE PRESIDENT

    • Officer
    		 80,967 2015-03-03 0

    BUTEL JEAN LUC CORPORATE VICE PRESIDENT

    • Officer
    		 42,732 2014-12-31 0

    DAVIS ROBERT M CORPORATE VICE PRESIDENT

    • Officer
    		 0 2014-03-04 0

    BATCHELOR PHILLIP L. CORPORATE VICE PRESIDENT

    • Officer
    		 0 2014-03-04 0

    RIEDEL NORBERT G CORPORATE VICE PRESIDENT

    • Officer
    		 56,689 2013-01-16 0

    BAUGHMAN MICHAEL J CORPORATE VICE PRESIDENT

    • Officer
    		 30,042 2013-01-16 0

    CHEN THOMAS FANG-TYAN

    • Director
    		 790 2012-11-12 0

    BOOMER WALTER E

    • Director
    		 25,002 2011-05-03 0

    GATLING JAMES M CORPORATE VICE PRESIDENT

    • Officer
    		 0 2011-03-04 0

    MARTIN JOSEPH B

    • Director
    		 8,637 2010-10-25 0

    AMUNDSON JOY A CORPORATE VICE PRESIDENT

    • Officer
    		 81,665 2010-03-15 0

    MCGILLIVRAY BRUCE CORPORATE VICE PRESIDENT

    • Officer
    		 52,566 2010-03-15 0

    ARDUINI PETER J CORPORATE VICE PRESIDENT

    • Officer
    		 68,975 2010-03-15 0

    WHITE CHERYL L CORPORATE VICE PRESIDENT

    • Officer
    		 31,401 2010-03-15 0

    TERRELL KARENANN K CORPORATE VICE PRESIDENT

    • Officer
    		 22,822 2010-03-15 0

    LICHTENSTEIN SUSAN R CORPORATE VICE PRESIDENT

    • Officer
    		 22,562 2009-03-16 0

    GREISCH JOHN J CORPORATE VICE PRESIDENT

    • Officer
    		 85,474 2009-03-16 0

    UTTS JAMES E CORPORATE VICE PRESIDENT

    • Officer
    		 217,764 2006-03-14 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    GRADE JOEL T. - Officer EVP AND CFO

    		2023-12-05 16:11:43 -0500 2023-12-01 A 25,189 a 53,177 direct

    GRADE JOEL T. - Officer EVP AND CFO

    		2023-12-05 16:11:43 -0500 2023-12-01 A 27,988 a 27,988 direct

    GRADE JOEL T. - Officer EVP AND CFO

    		2023-12-05 16:11:43 -0500 2023-12-01 A 102,273 a 102,273 direct

    STEVENS BRIAN - Officer SVP, CAO & CONTROLLER

    		2023-12-05 16:11:04 -0500 2023-12-01 A 13,994 a 53,532 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    BAXTER INTERNATIONAL INC. BAX 2023-12-06 19:45:04 UTC 5.07 0.25 0
    BAXTER INTERNATIONAL INC. BAX 2023-12-06 19:15:04 UTC 5.07 0.25 0
    BAXTER INTERNATIONAL INC. BAX 2023-12-06 18:45:03 UTC 5.07 0.25 0
    BAXTER INTERNATIONAL INC. BAX 2023-12-06 18:15:03 UTC 5.07 0.25 0
    BAXTER INTERNATIONAL INC. BAX 2023-12-06 17:45:03 UTC 5.07 0.25 0
    BAXTER INTERNATIONAL INC. BAX 2023-12-06 17:15:04 UTC 5.07 0.25 0
    BAXTER INTERNATIONAL INC. BAX 2023-12-06 16:45:04 UTC 5.07 0.25 0
    BAXTER INTERNATIONAL INC. BAX 2023-12-06 16:15:04 UTC 5.07 0.25 0
    BAXTER INTERNATIONAL INC. BAX 2023-12-06 15:45:03 UTC 5.07 0.25 0
    BAXTER INTERNATIONAL INC. BAX 2023-12-06 15:15:04 UTC 5.07 0.25 0
    BAXTER INTERNATIONAL INC. BAX 2023-12-06 14:45:04 UTC 5.07 0.25 0
    BAXTER INTERNATIONAL INC. BAX 2023-12-06 14:15:04 UTC 5.07 0.25 0
    BAXTER INTERNATIONAL INC. BAX 2023-12-06 13:45:04 UTC 5.07 0.25 0
    BAXTER INTERNATIONAL INC. BAX 2023-12-06 13:15:04 UTC 5.07 0.25 0
    BAXTER INTERNATIONAL INC. BAX 2023-12-05 22:15:04 UTC 5.07 0.25 0
    BAXTER INTERNATIONAL INC. BAX 2023-12-05 21:45:04 UTC 5.07 0.25 0
    BAXTER INTERNATIONAL INC. BAX 2023-12-05 21:15:04 UTC 5.07 0.25 0
    BAXTER INTERNATIONAL INC. BAX 2023-12-05 20:45:04 UTC 5.07 0.25 0
    BAXTER INTERNATIONAL INC. BAX 2023-12-05 20:15:04 UTC 5.07 0.25 0
    BAXTER INTERNATIONAL INC. BAX 2023-12-05 19:45:04 UTC 5.07 0.25 0

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    JPMorgan Trust IV- JPMorgan Value Plus Fund BAX -523.0 shares, $-45746.81 2019-09-30 N-PORT
    FundVantage Trust- Gotham Defensive Long Fund BAX -18.0 shares, $-1461.42 2020-03-31 N-PORT
    M3Sixty Funds Trust- AXS Market Neutral Fund BAX -1190.0 shares, $-95485.6 2020-12-31 N-PORT
    American Century Capital Portfolios, Inc.- AC Alternatives Market Neutral Value Fund BAX -1837.0 shares, $-147749.91 2021-09-30 N-PORT
    AQR Funds- AQR Alternative Risk Premia Fund BAX -5978.0 shares, $-225609.72 2023-09-30 N-PORT
    AdvisorShares Trust- AdvisorShares Dorsey Wright Short ETF BAX -6447.0 shares, $-243309.78 2023-09-29 N-PORT
    FundVantage Trust- Gotham Enhanced 500 Plus Fund BAX -103.0 shares, $-3887.22 2023-09-29 N-PORT
    INVESTMENT MANAGERS SERIES TRUST II- AXS Market Neutral Fund BAX -2902.0 shares, $-109521.48 2023-09-30 N-PORT
    Leuthold Funds Inc- Leuthold Core Investment Fund BAX -16484.0 shares, $-622106.16 2023-09-30 N-PORT
    Leuthold Funds Inc- Leuthold Grizzly Short Fund BAX -22673.0 shares, $-855679.02 2023-09-30 N-PORT
    Leuthold Funds Inc- Leuthold Global Fund BAX -351.0 shares, $-13246.74 2023-09-30 N-PORT
    GLENMEDE FUND INC- Quantitative U.S. Long/Short Equity Portfolio BAX -11140.0 shares, $-361270.2 2023-10-31 N-PORT

    Congressional Transactions Past 6-Months

    To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***
    Congress Person Party Chamber Filing Filing Date Transaction Date Security Type Owner Transaction Amount
    senator Daniel S Sullivan republican Senate Filing 2023-07-26 2022-11-30 JT S $1,001-$15,000
    WhaleWisdom Logo

    Elevate your investments